The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Enhancement of antibiotics antimicrobial activity due to the silver nanoparticles impact on the cell membrane
Open accessAbstract
The ability of microorganisms to generate resistance outcompetes with the generation of new and efficient antibiotics; therefore, it is critical to develop novel antibiotic agents and treatments to control bacterial infections. An alternative to this worldwide problem is the use of nanomaterials with antimicrobial properties. Silver nanoparticles (AgNPs) have been extensively studied due to their antimicrobial effect in different organisms. In this work, the synergistic antimicrobial effect of AgNPs and conventional antibiotics was assessed in Gram-positive and Gram-negative bacteria. AgNPs minimal inhibitory concentration was 10-12 μg mL-1 in all bacterial strains tested, regardless of their different susceptibility against antibiotics. Interestingly, a synergistic antimicrobial effect was observed when combining AgNPs and kanamycin according to the fractional inhibitory concentration index, FICI: <0.5), an additive effect by combining AgNPs and chloramphenicol (FICI: 0.5 to 1), whereas no effect was found with AgNPs and β-lactam antibiotics combinations. Flow cytometry and TEM analysis showed that sublethal concentrations of AgNPs (6-7 μg mL-1) altered the bacterial membrane potential and caused ultrastructural damage, increasing the cell membrane permeability. No chemical interactions between AgNPs and antibiotics were detected. We propose an experimental supported mechanism of action by which combinatorial effect of antimicrobials drives synergy depending on their specific target, facilitated by membrane alterations generated by AgNPs. Our results provide a deeper understanding about the synergistic mechanism of AgNPs and antibiotics, aiming to combat antimicrobial infections efficiently, especially those by multi-drug resistant microorganisms, in order to mitigate the current crisis due to antibiotic resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
The bactericidal effect of silver nanoparticles
Morones, J. R., Elechiguerra, J. L., Camacho, A., Holt, K., Kouri, J. B., Ramírez, J. T., & Yacaman, M. J. (2005) · Nanotechnology · doi:10.1088/0957-4484/16/10/059 · Cited by 6,668
Sondi, I., & Salopek-Sondi, B. (2004) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2004.02.012 · Cited by 5,986
Antimicrobial effects of silver nanoparticles
Kim, J. S., Kuk, E., Yu, K. N., Kim, J.-H., Park, S. J., Lee, H. J., Kim, S. H., Park, Y. K., Park, Y. H., Hwang, C.-Y., et al. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.12.001 · Cited by 4,918
Performance standards for antimicrobial susceptibility testing
Weinstein, M. P., & Clinical (2019) · Clinical and Laboratory Standards Institute eBooks · Cited by 4,341
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892
Synergy, antagonism, and what the chequerboard puts between them
Odds, F. C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg301 · Cited by 2,481
Mechanistic Basis of Antimicrobial Actions of Silver Nanoparticles
Dakal, T. C., Kumar, A., Majumdar, R. S., & Yadav, V. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01831 · Cited by 2,135
Huh, A. J., & Kwon, Y. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.002 · Cited by 1,864
Interaction of silver nanoparticles with HIV-1
Elechiguerra, J. L., Burt, J. L., Morones, J. R., Camacho-Bragado, A., Gao, X., Lara, H. H., & Yacaman, M. J. (2005) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-3-6 · Cited by 1,709
Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli
Li, W.-R., Xie, X.-B., Shi, Q.-S., Zeng, H.-Y., OU-Yang, Y.-S., & Chen, Y.-B. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2159-5 · Cited by 1,697
Proteomic Analysis of the Mode of Antibacterial Action of Silver Nanoparticles
Lok, C.-N., Ho, C.-M., Chen, R., He, Q.-Y., Yu, W.-Y., Sun, H., Tam, P. K.-H., Chiu, J.-F., & Che, C.-M. (2006) · Journal of Proteome Research · doi:10.1021/pr0504079 · Cited by 1,581
Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity
Durán, N., Durán, M., de Jesus, M. B., Seabra, A. B., Fávaro, W. J., & Nakazato, G. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.11.016 · Cited by 1,542
Nanotechnology as a therapeutic tool to combat microbial resistance
Pelgrift, R. Y., & Friedman, A. J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.011 · Cited by 1,432
Fayaz, A. M., Balaji, K., Girilal, M., Yadav, R., Kalaichelvan, P. T., & Venketesan, R. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.04.006 · Cited by 1,417
Size Dependent and Reactive Oxygen Species Related Nanosilver Toxicity to Nitrifying Bacteria
Choi, O., & Hu, Z. (2008) · Environmental Science & Technology · doi:10.1021/es703238h · Cited by 1,391
Shahverdi, A. R., Fakhimi, A., Shahverdi, H. R., & Minaian, S. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2007.02.001 · Cited by 1,299
Antifungal activity of silver nanoparticles against Candida spp.
Panáček, A., Kolář, M., Večeřová, R., Prucek, R., Soukupová, J., Kryštof, V., Hamal, P., Zbořil, R., & Kvítek, L. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.065 · Cited by 964
Biogenic synthesis of nanoparticles: A review
Sharma, D., Kanchi, S., & Bisetty, K. (2019) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2015.11.002 · Cited by 948
Silver Enhances Antibiotic Activity Against Gram-Negative Bacteria
Morones-Ramirez, J. R., Winkler, J. A., Spina, C. S., & Collins, J. J. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006276 · Cited by 756
Taubes, G. (2008) · Science · doi:10.1126/science.321.5887.356 · Cited by 751
Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds
Lara, H. H., Garza-Treviño, E. N., Ixtepan-Turrent, L., & Singh, D. K. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-30 · Cited by 741
Industrial Food Animal Production, Antimicrobial Resistance, and Human Health
Silbergeld, E. K., Graham, J., & Price, L. B. (2008) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.29.020907.090904 · Cited by 635
Nanopharmaceuticals (part 1): products on the market
Weissig, V., Pettinger, T., & Murdock, N. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s46900 · Cited by 591
Nanoparticles: Alternatives Against Drug-Resistant Pathogenic Microbes
Rudramurthy, G., Swamy, M., Sinniah, U., & Ghasemzadeh, A. (2016) · Molecules · doi:10.3390/molecules21070836 · Cited by 556
Synergistic antibacterial effects of β-lactam antibiotic combined with silver nanoparticles
Li, P., Li, J., Wu, C., Wu, Q., & Li, J. (2005) · Nanotechnology · doi:10.1088/0957-4484/16/9/082 · Cited by 508
After 2015: infectious diseases in a new era of health and development
Dye, C. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0426 · Cited by 361
Deng, H., McShan, D., Zhang, Y., Sinha, S. S., Arslan, Z., Ray, P. C., & Yu, H. (2016) · Environmental Science & Technology · doi:10.1021/acs.est.6b00998 · Cited by 307
Standards for antimicrobial susceptibility testing.
Walker, R. D. (1999) · PubMed · Cited by 288
Xu, H., Qu, F., Xu, H., Lai, W., Andrew Wang, Y., Aguilar, Z. P., & Wei, H. (2012) · BioMetals · doi:10.1007/s10534-011-9482-x · Cited by 284
Novo, D. J., Perlmutter, N. G., Hunt, R. H., & Shapiro, H. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.827-834.2000 · Cited by 261
Vazquez-Muñoz, R., Borrego, B., Juárez-Moreno, K., García-García, M., Mota Morales, J. D., Bogdanchikova, N., & Huerta-Saquero, A. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.05.007 · Cited by 227
Self-citationUltrastructural analysis of Candida albicans when exposed to silver nanoparticles
Vazquez-Muñoz, R., Avalos-Borja, M., & Castro-Longoria, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108876 · Cited by 168
Kora, A. J., & Rastogi, L. (2013) · Bioinorganic Chemistry and Applications · doi:10.1155/2013/871097 · Cited by 165
Antimicrobial resistance: action to combat the rising microbial challenges
Paphitou, N. I. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.04.007 · Cited by 163
Antifungal Susceptibility Testing: Clinical Laboratory and Standards Institute (CLSI) Methods
Fothergill, A. W. (2012) · Interactions of Yeasts, Moulds, and Antifungal Agents · doi:10.1007/978-1-59745-134-5_2 · Cited by 163
Cassell, G. H. (2001) · JAMA · doi:10.1001/jama.285.5.601 · Cited by 162
Pricing infectious disease: The economic and health implications of infectious diseases
Fonkwo, P. N. (2008) · EMBO reports · doi:10.1038/embor.2008.110 · Cited by 161
Panáček, A., Smékalová, M., Večeřová, R., Bogdanová, K., Röderová, M., Kolář, M., Kilianová, M., Hradilová, Š., Froning, J. P., Havrdová, M., et al. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2016.03.007 · Cited by 161
Reconnaissance of 47 antibiotics and associated microbial risks in seafood sold in the United States
Done, H. Y., & Halden, R. U. (2014) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2014.08.075 · Cited by 156
Borrego, B., Lorenzo, G., Mota-Morales, J. D., Almanza-Reyes, H. E., Mateos, F., López-Gil, E., de la Losa, N., Burmistrov, V. A., Pestryakov, A. N., Brun, A., et al. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.01.021 · Cited by 134
Self-citationRecent trends of nanomedicinal approaches in clinics
Dilnawaz, F., Acharya, S., & Sahoo, S. K. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.01.016 · Cited by 129
Juárez‐Moreno, K., Gonzalez, E., Girón-Vázquez, N. G., Chávez-Santoscoy, R. A., Mota-Morales, J. D., Pérez-Mozqueda, L. L., Garcia-Garcia, M., Pestryakov, A. N., & Bogdanchikova, N. (2016) · Human & Experimental Toxicology · doi:10.1177/0960327116675206 · Cited by 84
Self-citationYang, Y., Xiang, Y., & Xu, M. (2015) · Scientific Reports · doi:10.1038/srep18583 · Cited by 76
Romero-Urbina, D., Lara, H. H., Velázquez‐Salazar, J. J., Arellano-Jiménez, M. J., Larios, E., Srinivasan, A., Lopez-Ribot, J. L., & Yacamán, M. J. (2015) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.6.246 · Cited by 72
de Souza, A., Mehta, D., & Leavitt, R. W. (2006) · Cited by 33
Liu, X., Ma, L., Chen, F., Liu, J., Yang, H., & Lu, Z. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.04.001 · Cited by 31
Cited by
Silver Nanoparticles and Their Antibacterial Applications
Bruna, T., Maldonado-Bravo, F., Jara, P., & Caro, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137202 · Cited by 1,708
Salleh, A., Naomi, R., Utami, N. D., Mohammad, A. W., Mahmoudi, E., Mustafa, N., & Fauzi, M. B. (2020) · Nanomaterials · doi:10.3390/nano10081566 · Cited by 581
Yeh, Y.-C., Huang, T.-H., Yang, S.-C., Chen, C.-C., & Fang, J.-Y. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00286 · Cited by 416
Synergistic Effects Between Metal Nanoparticles and Commercial Antimicrobial Agents: A Review
Ribeiro, A. I., Dias, A. M., & Zille, A. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c03891 · Cited by 276
León-Buitimea, A., Garza-Cárdenas, C. R., Garza-Cervantes, J. A., Lerma-Escalera, J. A., & Morones-Ramírez, J. R. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01669 · Cited by 274
Metadata
- Authors
- Vazquez-Muñoz, R., Meza-Villezcas, A., Fournier, P. G. J., Soria-Castro, E., Juarez-Moreno, K., Gallego-Hernández, A. L., Bogdanchikova, N., Vazquez-Duhalt, R., & Huerta-Saquero, A.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-11-08
- Volume
- 14
- Issue
- 11
- Pages
- e0224904
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2985004336
- Cited by
- 307
- References
- 47
- FWCI
- 11.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.